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Abstract Werner syndrome is a hereditary disease character-
ized by cancer predisposition, genetic instability, and the
premature appearance of features associated with normal aging.
At the molecular level this syndrome has been related to
mutations in the Werner helicase, a member of the RecQ family
of DNA helicases which are required to maintain genomic
stability in cells. Here we show by a yeast two-hybrid screen that
the Werner helicase can directly interact with the regulatory
subunit (RIL) of cAMP protein kinase A (PKA). We confirm
that this interaction occurs in vivo. Interestingly, serum with-
drawal causes a redistribution of the Werner helicase within the
nucleus of mammalian cells. Raising intracellular cAMP levels
or increased expression of the regulatory but not the catalytic
subunit of PKA inhibits this nuclear redistribution stimulated by
serum deprivation. These results suggest that similar to lower
organisms, gene products linked to genomic instability and aging
may be directly regulated by growth factor-sensitive, PKA-
dependent pathways. + 2002 Published by Elsevier Science
B.V. on behalf of the Federation of European Biochemical So-
cieties.
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1. Introduction
Individuals with Werner’s progeria manifest a premature
onset of age-related phenotypes such as type II diabetes, os-
teoporosis and atherosclerosis [1]. Most a¥icted patients suc-
cumb by their fourth decade usually from either a myocardial
infarction or cancer. Genetic analysis has demonstrated that
a¡ected individuals have homozygous mutations in a gene
product encoding a member of the RecQ family of DNA
helicases. Disruptions in genes belonging to this family ^
BLM, WRN and RecQ4 ^ are associated with distinct clinical
disorders: Bloom’s syndrome, Werner’s syndrome and Roth-
mund^Thomson syndrome, respectively. Patients with these
disorders show a signi¢cant predisposition to the development
of cancer, which highlights the important role of RecQ heli-
cases in sustaining genomic stability and preventing tumor
formation. Biochemical studies have implicated the Werner
helicase in a host of diverse processes including DNA repli-
cation, repair and recombination [1^3]. This helicase seems to
be responsible for resolving aberrant DNA structures that
form after DNA damage or during normal DNA replication.
Mutations in WRN prevent the repair of these structures and
result in increased genetic instability. Cells derived from
Werner syndrome patients show accelerated telomere short-
ening, chromosomal instability and shorter in vitro life span
[4,5].
In this report we describe an association between the Wer-
ner helicase and a subunit of protein kinase A (PKA), and
demonstrate that this association is involved in the dynamic
nuclear re-distribution of the Werner gene product stimulated
by nutrient withdrawal. Although the response to caloric re-
striction is undoubtedly complex, in yeast glucose is known to
increase cAMP levels through a Ras-dependent signaling
pathway. The rise in cAMP triggers the dissociation of the
catalytic subunit of PKA (Tpk) from its regulatory subunit
(Bcy1). The importance of this pathway is strengthened by a
number of studies demonstrating that yeast life span is aug-
mented either by caloric restriction or by mutations in certain
upstream elements that regulate PKA-dependent signaling
[6,7]. Recent evidence suggests that the life extension induced
by caloric restriction requires Sir2, a member of the family of
NAD-dependent histone deacetylases implicated in gene si-
lencing and genomic stability [8]. Thus, with regard to longev-
ity, Sir2 may act as a downstream e¡ector of PKA signaling
in yeast. Furthermore, PKA directly regulates UV-damaged
DNA repair in cell-free yeast extracts [9]. Taken together,
these results suggest that in yeast there is a pathway that
couples nutrient supply, PKA activity and genomic stability.
The interaction of the Werner protein with PKA described in
this article o¡ers a new perspective on the interrelation of
these three processes in mammalian cells.
2. Materials and methods
2.1. Yeast and mammalian two-hybrid analysis
The C-terminus of WRN, WRN-C (amino acids 859^1432), was
created by PCR ampli¢cation from full-length human WRN cDNA
(kindly provided by J. Oshima, International Registry of Werner Syn-
drome, University of Washington, Seattle, WA, USA) and was sub-
cloned into a pGBKT7 yeast expression vector (Clontech) in frame
with the GAL4 DNA binding domain (BD). The BD-WRN-C bait
was transformed into AH109 yeast strain, and then mated with Y187
yeast cells pretransformed with a human brain cDNA library fused to
the GAL4 activation domain (Clontech HL4004AH). The two-hybrid
screen was performed according to the manufacturer’s recommenda-
tions with approximately 1.5U106 independent clones analyzed.
To localize the putative binding domains, truncated WRN cDNAs
were prepared by PCR ampli¢cation from full-length human WRN
cDNA and subcloned into pGBKT7. These truncated baits were co-
transformed with pACT2-PKA-RIL into the AH109 yeast strain, and
co-transformants were selected on SD/Leu-/Trp-/His-/Ade- with X-K-
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galactosidase to assess reporter gene activation. Full-length PKA-RIL
and variously truncated PKA-RIL cDNAs were prepared by PCR
ampli¢cation from a PKA-RIL full-length cDNA obtained from In-
cyte Genomics (Clone ID 1290180), and subcloned into pGADT7 in
frame with the GAL4 activation domain. All constructs were veri¢ed
by direct sequencing.
For the mammalian two-hybrid assay, WRN-C and full-length
PKA-RIL were subcloned into a pM-GAL4-DNA-BD and pVP-16
mammalian expression vectors, respectively (Clontech). pM-BD-
WRN-C and pVP-16-PKA-RIL were transiently co-transfected as de-
scribed below into HeLa cells along with pG5CAT, a plasmid con-
taining the CAT reporter gene under the control of ¢ve tandem GAL4
binding sites (Clontech). HeLa cells were harvested 72 h after trans-
fection and the lysate prepared for a CAT ELISA assay following the
manufacturer’s recommendations (Boehringer Mannheim).
2.2. Immunoprecipitation and immunoblotting
WRN-C and full-length PKA-RIL were subcloned into pCMV-Tag-
myc and pCMV-Tag-Flag mammalian expression vectors respectively
(Stratagene). Equal amounts of WRN-C-myc and PKA-RIL-Flag
were transiently co-transfected into HeLa cells (2.5 Wg total DNA/
well of a six-well dish) using Lipofectamine 2000 according to the
manufacturer’s recommendations (Life Technologies). Extracts en-
riched in both nuclear and nucleolar proteins were prepared, with
modi¢cations, as previously described [10,11] Brie£y, transfected
HeLa cells were harvested on ice in lysis bu¡er (10 mM Tris^HCl,
pH 7.4/10 mM KCl/2 mM MgCl2/0.05% Triton X-100/1 mM EGTA)
supplemented with protease inhibitor cocktail (Complete, Boehringer
Mannheim). Extracts (approximately 2 mg total protein) were then
sonicated on ice followed by centrifugation at 4000Ug for 5 min. The
¢rst supernatant was retained and the remaining pellet was then addi-
tionally extracted in the above lysis bu¡er supplemented with 300 mM
KCl. After a second centrifugation, the second supernatant was com-
bined with the original. Nonidet P-40 was added to a ¢nal concen-
tration of 1%. The nuclear-enriched extract was then pre-cleared with
normal mouse IgG and Gammabind Plus Sepharose beads (Amer-
sham Pharmacia) for 1 h at 4‡C, centrifuged and normalized for
protein concentration. The supernatant was then incubated overnight
at 4‡C with anti-Flag M2 a⁄nity gel (Sigma). The a⁄nity gel was
precipitated by centrifugation and washed ¢ve times with 1Uwash
bu¡er (Sigma). Flag-tagged proteins were subsequently eluted and
resuspended in sample bu¡er. Samples were analyzed on 12% SDS^
PAGE gels and immunoblotted with either 1:1000 anti-Flag M2
mouse monoclonal antibody (Sigma), or 1:500 anti-myc mouse mono-
clonal antibody (Santa Cruz Biotechnology) and ¢nally visualized by
chemiluminescence.
2.3. Fluorescent microscopy
To obtain WRN^GFP, full-length WRN was subcloned in frame
into the green £uorescent protein (GFP) expression vector pEGFP-C1
Fig. 1. The carboxy-terminus of the Werner helicase and PKA-RIL interact in yeast. A: Speci¢c interaction between WRN-C and PKA-RIL
supports growth while no interaction is observed using p53, human PGC-1 or empty vector alone as bait. B: Growth and K-galactosidase re-
porter activity in yeast de¢nes a region of WRN-C required for the interaction with PKA-RIL, that encompasses a domain conserved among a
number of RecQ helicases. C: The C-terminal domain of PKA-RIL is not required for interaction with WRN-C.
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(Clontech). HeLa cells were transfected as described above, and 18 h
post-transfection cells were either maintained in Dulbecco’s modi¢ed
essential medium (DMEM) supplemented with 10% serum or placed
in DMEM without serum. Transfected cells were then incubated for
an additional 24 h prior to assessment with a Nikon TE300 £uores-
cent microscope. To determine the role of cyclic nucleotides, cells were
incubated with either vehicle alone, 10 mM 8-bromo-cAMP, or 10 mM
8-bromo-cGMP, with each agent added at the time of serum with-
drawal. In other experiments, cells were co-transfected with WRN^
GFP (1.25 Wg) and equal amounts of either pCMV-RIL-Flag, pCMV-
CIK V5 or empty vector. The initial CIK clone was a generous gift of
Y.S. Cho-Chung (NIH), was ampli¢ed by PCR and subcloned into a
V5 epitope-tagged expression vector and then con¢rmed by direct
sequencing. Approximately 7^10 random ¢elds (40U) were photo-
graphed for each condition and the number of punctates in 50^100
GFP-positive cells determined. All studies were repeated at least three
times with similar results.
3. Results
To further extend the known functions of the Werner heli-
case we performed a yeast two-hybrid screen using the C-
terminal domain (amino acids 859^1432) of the molecule as
bait (WRN-C). This region of the molecule is devoid of any
known exonuclease or helicase activity. A brain library was
screened to potentially enrich for protein partners that were
independent of DNA replication. From this library, we iden-
ti¢ed a number of potential interacting molecules including a
subunit of the COP9 signalosome, Surf-4 as well as two ex-
pressed sequence tags of unknown function. In addition to
these potential candidate interacting proteins we also identi-
¢ed the PKA regulatory subunit RIL. As demonstrated in Fig.
1A, in yeast PKA-RIL could speci¢cally interact with the
C-terminal domain of the Werner helicase. To determine
which part of the helicase was required for this interaction
we next made a series of C-terminal constructs. As demon-
strated in Fig. 1B, amino acids 859^1066 of the helicase were
su⁄cient for interaction while no activation was seen with
various constructs comprising amino acids 1000^1432. Inter-
estingly, the region comprising amino acids 859^1066 contains
a domain of previously unknown function that is well con-
served among several members of the RecQ helicases [12].
Similarly, analysis of PKA-RIL demonstrated that the car-
boxy-terminus of this molecule was dispensable for interaction
with the Werner helicase (Fig. 1C). As such, binding appeared
independent of at least one of the two conserved cAMP bind-
ing motifs found in all regulatory subunits.
To con¢rm that the interaction observed in the yeast two-
hybrid system occurs in vivo, we next prepared epitope-tagged
forms of WRN-C (WRN-myc) and full-length PKA-RIL (R1-
Flag). Transfection of these constructs into HeLa cells dem-
onstrated expression of both constructs using myc- or Flag
epitope-speci¢c antibodies (Fig. 2A). We next prepared nu-
clear extracts from cells transfected with both WRN-myc
and RIL-Flag. Immunoprecipitation of PKA-RIL from nu-
clear extracts of transfected cells demonstrated an association
with the WRN-myc gene product (Fig. 2B). Reciprocal im-
munoprecipitation of WRN-myc did not allow for unambig-
uous identi¢cation of co-precipitated PKA-RIL since the reg-
ulatory subunit is similar in size to the immunoglobulin heavy
chain (data not shown). In an e¡ort to further con¢rm that
the two proteins interacted in vivo we performed a mamma-
lian two-hybrid assay [13]. As noted in Fig. 2C, the combina-
Fig. 2. The Werner helicase and PKA-RIL interact in vivo. A: Ex-
pression as assessed by Western blot (WB) analysis of epitope-
tagged Werner helicase (WRN-myc) and PKA-RIL (RIL-Flag) in
transfected HeLa cells. Expression represents levels of transfected
protein in 50 Wg of nuclear-enriched protein lysate. B: Immunopre-
cipitation (IP) with Flag antibody of 80 Wg enriched nuclear extract
derived initially from 2 mg of total protein lysate. WRN-myc is
only co-precipitated in cells expressing RIL-Flag. C: Mammalian
two-hybrid assay using plasmids expressing the GAL-4 DNA bind-
ing domain (BD) and the activation domain from VP-16. Fusion
proteins encoding BD and Werner helicase (BD-WRN) as well as
VP-16 and PKA-RIL (VP16-R1) were tested independently and to-
gether for reporter activation. Only the combinations of WRN and
PKA-RIL fusion constructs were su⁄cient to activate transcription.
Results are the mean values of duplicate determinations from one
of two similar experiments.
Fig. 3. Serum regulates the nuclear distribution of the Werner heli-
case. A: Under normal growth conditions, WRN^GFP in trans-
fected HeLa cells shows a punctate nuclear distribution. B: Twenty-
four hours after serum withdrawal the distribution of WRN^GFP
is more di¡use within the nucleus. C: Total levels of WRN^GFP
do not change appreciably following the withdrawal of serum.
D: Quanti¢cation of the number of punctates within the nucleus
con¢rms the redistribution stimulated by serum withdrawal.
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tion of Werner helicase and PKA-RIL strongly and speci¢-
cally stimulated reporter activation.
We next constructed a fusion protein containing full-length
Werner helicase and GFP (WRN^GFP) in order to obtain
additional functional information regarding the role of RIL
in the regulation of the Werner helicase. Co-immunoprecipi-
tation experiments demonstrated that this chimeric protein
still interacted with PKA-RIL (data not shown). As observed
in Fig. 3A, expression of WRN^GFP demonstrated that, as
has been previously described using immunohistochemical
analysis of endogenous protein, the WRN^GFP molecule ap-
pears to localize within discrete sub-domains in the nucleus
previously identi¢ed as the nucleolus [14,15]. In contrast, 24 h
following serum withdrawal the distribution of WRN^GFP
was more uniform within the nucleus (Fig. 3B). As previously
observed, this serum withdrawal-induced redistribution oc-
curred without a signi¢cant change in helicase levels [14].
This is also evident from Fig. 3C where it is demonstrated
that in the presence or absence of serum, total levels of
WRN^GFP are not signi¢cantly altered. In an e¡ort to quan-
titate this e¡ect, we counted the number of GFP-positive nu-
clear punctates per cell under normal growth conditions and
in the setting of serum withdrawal. As demonstrated in Fig.
3D, consistent with the observed di¡usion of the WRN^GFP,
serum withdrawal resulted in a signi¢cant reduction in ob-
served nuclear punctates per cell. In numerous experiments
(n=6), when compared to serum-containing conditions, the
percentage decrease of nuclear punctates induced by serum
withdrawal ranged from 60 to 90%.
In an e¡ort to assess whether the interaction of Werner
helicase with a component of PKA played a role in the sub-
cellular distribution of the helicase, we next examined the role
of intracellular cAMP. As demonstrated in Fig. 4A, in the
setting of serum withdrawal, levels of nuclear punctates
were low in untreated cells. Administration of a cell-permeant
form of cAMP but not cGMP throughout the period of serum
deprivation resulted in maintenance of nuclear punctates.
Since a rise in intracellular cAMP triggers an increase in the
free levels of both the catalytic and regulatory subunits of
PKA, we next sought to assess the role of each of these com-
ponents separately. As demonstrated in Fig. 4B, increased
expression of the catalytic subunit (CIK) had little e¡ect on
the redistribution of the helicase in the setting of serum with-
drawal. In contrast, expression of the RIL subunit prevented
the nuclear redistribution induced by the withdrawal of serum
(Fig. 4C).
4. Discussion
Our data demonstrate an interaction of the Werner helicase
with a regulatory subunit of PKA and implicate this associa-
tion with the nuclear distribution of the helicase. In particular,
the redistribution of the helicase induced by serum withdrawal
is inhibited by increased regulatory subunit expression and by
cAMP but not by the catalytic subunit of PKA. This data
suggest the regulatory subunit role in helicase localization is
most likely independent of its role in the regulation of cata-
lytic activity. Other examples of regulatory subunit activity
that is independent of kinase activity have been previously
described. For instance, in yeast, expression of RAS2val19
leads to a number of nutritional alterations that can be sup-
pressed by expression of MSI1, a subunit of chromatin assem-
bly factor-1 [16]. Recent evidence suggests that MSI1 over-
expression inhibits the RAS2val 19 phenotype not by lowering
cAMP levels or directly a¡ecting catalytic (Tpk) subunit ac-
tivity, but rather MSI1 appears to mediate its e¡ects through
the regulatory subunit Bcy1 [17]. Similarly, there is also evi-
dence in mammalian cells suggesting that the regulatory sub-
unit may have e¡ects that are independent of its negative
regulation of catalytic subunit activity. Indeed, some early
studies demonstrated that the RII subunit interacts with
DNA and possesses type I topoisomerase activity [18]. In
addition, certain mutants of R1K appear to confer increased
resistance to the DNA-damaging agent cisplatin in a catalytic
subunit-independent fashion [19]. Finally, recent evidence sug-
gests that PKA regulatory subunits may potentially function
as tumor suppressors [20].
Previous studies have demonstrated that the human Werner
helicase gene product is localized to the nucleolus [13,14,21].
To date little is known about what regulates the import, ex-
port or retention of proteins within this sub-nuclear structure.
Although the nucleolus is best known as the site for the pro-
cessing and synthesis of an array of riboproteins, increasing
evidence suggests that this structure is also important in se-
questering a host of DNA repair and cell cycle regulatory
gene products [22]. Although in dividing cells the human
Werner helicase (hWRN) localizes to the nucleolus, the mouse
gene product (mWRN), in contrast, is always found uniformly
distributed throughout the nucleus [13,14]. Surprisingly, even
when hWRN is expressed in mouse cells, the human helicase
fails to localize within the nucleolus [23], suggesting a poten-
tial fundamental di¡erence in nucleolar tra⁄cking between
species. Given that human and mouse WRN gene products
have similar enzymatic activities, the failure of the mouse gene
product to localize to the nucleolus has been proposed as an
explanation for why mice with targeted deletions of mWRN
fail to manifest symptoms of accelerated aging [23]. As such, it
has been proposed that the nucleolar activity of hWRN may
represent a critical aspect of the gene product’s ability to
regulate life span.
The Werner helicase has been shown to interact with a
number of proteins including RPA, PCNA, N-polymerase,
KU, p53, DNA-dependent kinase and £ap endonuclease 1
[12,24^30]. Each of these proteins is involved in DNA pro-
cessing events such as repairing DNA damage or resolving
aberrant DNA structures. These studies have strengthened
the hypothesis that the Werner gene product plays an impor-
tant role in the repair of DNA damage and in DNA replica-
tion. Nonetheless, other DexH-containing helicases which are
Fig. 4. The role of cAMP and PKA in Werner helicase localization.
A: Incubation with a cAMP analogue inhibits the nuclear redistri-
bution of WRN^GFP stimulated by serum withdrawal. B: The re-
distribution induced by serum withdrawal is not a¡ected by over-ex-
pression of CIK. C: Expression of RIL blocks Werner helicase
redistribution stimulated by nutrient withdrawal.
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not associated with premature aging have very similar enzy-
matic function and can in some cases associate with similar
proteins. As such, the results presented here provide addition-
al insight into Werner function by providing a direct link
between metabolic state, PKA activity and helicase sub-cellu-
lar localization. Furthermore, they strengthen the notion that
at least some of the paradigms established in simple organisms
such as yeast may have direct relevance to the study of human
aging, genetic stability and carcinogenesis.
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